ARCHIVES

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Advisors tell NCI to rethink contracts for clinical trials cooperative group tissue banks

November 21, 2003

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Ad Council, ACS Begin Ad Campaign To Promote Colon Cancer Screening.

February 1, 2002

In Brief: NCI Still Undecided Over Small Hospital Segment Of CHOP; Multihospital Proposals Review Nov. 14-15

November 2, 1979

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976

Cancer Congress Program Developed

June 27, 1980